Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Aldrich

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Amino Acids|March 28, 2008
Solid phase and solution synthesis of NvocLys(CO(CH2)5NH-NBD)OCH2CN, a trifunctional fluorescent lysine derivativeKshitij A Patkar, W Edward Highsmith, Jane V Aldrich
Journal of Medicinal Chemistry|January 9, 2004
Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3Balvinder S Vig, Thomas F Murray, Jane V Aldrich
Biopolymers|May 3, 2017
Alanine scan of the opioid peptide dynorphin B amideAnand A Joshi, Thomas F Murray, Jane V Aldrich
Journal of Medicinal Chemistry|July 16, 2008
High affinity conformationally constrained nociceptin/orphanin FQ(1-13) amide analoguesLaksana Charoenchai, Hongyan Wang, Jia Bei Wang, et al.
Journal of Medicinal Chemistry|July 23, 2009
Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptorsBhaswati Sinha, Zhengyu Cao, Thomas F Murray, et al.
Journal of Medicinal Chemistry|September 1, 2009
Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesisWei-Jie Fang, Yanjun Cui, Thomas F Murray, et al.
Journal of Medicinal Chemistry|July 8, 2005
[Nalpha-benzylTyr1,cyclo(D-Asp5,Dap8)]- dynorphin A-(1-11)NH2 cyclized in the "address" domain is a novel kappa-opioid receptor antagonistKshitij A Patkar, Xiuzhen Yan, Thomas F Murray, et al.
European Journal of Pharmacology|June 15, 2007
Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodynA N Carey, K Borozny, J V Aldrich, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 18, 2021
Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assayYuanzi Zhao, Anand A Joshi, Jane V Aldrich, et al.
Journal of Medicinal Chemistry|June 23, 1995
Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequenceS Arttamangkul, T F Murray, G E DeLander, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Amino Acids|March 28, 2008
Solid phase and solution synthesis of NvocLys(CO(CH2)5NH-NBD)OCH2CN, a trifunctional fluorescent lysine derivativeKshitij A Patkar, W Edward Highsmith, Jane V Aldrich
Journal of Medicinal Chemistry|January 9, 2004
Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3Balvinder S Vig, Thomas F Murray, Jane V Aldrich
Biopolymers|May 3, 2017
Alanine scan of the opioid peptide dynorphin B amideAnand A Joshi, Thomas F Murray, Jane V Aldrich
Journal of Medicinal Chemistry|July 16, 2008
High affinity conformationally constrained nociceptin/orphanin FQ(1-13) amide analoguesLaksana Charoenchai, Hongyan Wang, Jia Bei Wang, et al.
Journal of Medicinal Chemistry|July 23, 2009
Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptorsBhaswati Sinha, Zhengyu Cao, Thomas F Murray, et al.
Journal of Medicinal Chemistry|September 1, 2009
Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesisWei-Jie Fang, Yanjun Cui, Thomas F Murray, et al.
Journal of Medicinal Chemistry|July 8, 2005
[Nalpha-benzylTyr1,cyclo(D-Asp5,Dap8)]- dynorphin A-(1-11)NH2 cyclized in the "address" domain is a novel kappa-opioid receptor antagonistKshitij A Patkar, Xiuzhen Yan, Thomas F Murray, et al.
European Journal of Pharmacology|June 15, 2007
Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodynA N Carey, K Borozny, J V Aldrich, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 18, 2021
Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assayYuanzi Zhao, Anand A Joshi, Jane V Aldrich, et al.
Journal of Medicinal Chemistry|June 23, 1995
Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequenceS Arttamangkul, T F Murray, G E DeLander, et al.
Pageof 9